Standout Papers
Immediate Impact
35 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
2024 Standout
Works of Fengwei Li being referenced
The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion
2023
Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fengwei Li | 210 | 67 | 272 | 68 | 23 | 488 | |
| Qiao Wang | 267 | 45 | 294 | 51 | 25 | 539 | |
| Dan Kong | 179 | 40 | 301 | 39 | 34 | 520 | |
| Manar Atyah | 195 | 53 | 275 | 114 | 27 | 518 | |
| Yu Hou | 208 | 45 | 300 | 68 | 30 | 513 | |
| Sheng Zhao | 180 | 77 | 313 | 36 | 20 | 550 | |
| Lei Yan | 156 | 48 | 213 | 39 | 28 | 425 | |
| Zeran Yang | 277 | 49 | 323 | 36 | 16 | 532 | |
| Li Xu | 170 | 74 | 161 | 49 | 31 | 539 | |
| Yang Zhang | 121 | 40 | 196 | 42 | 22 | 421 | |
| Naiqing Zhao | 153 | 27 | 233 | 44 | 19 | 491 |
All Works
Login with ORCID to disown or claim papers
Loading papers...